Miconazole nitrate with hydrocortisone
Generic name
Miconazole nitrate with hydrocortisone
Brand name
ATC Code
D01AC20
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
Systemic absorption of miconazole in children is very low or below the limit of detection (which is < 1 ng/ml)
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Skin infections by dermatophytes or Candida species |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
The likelihood of local and systemic effects increases with use in children and with prolonged use: use under occlusion and use on large surfaces
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Be careful when using in children (thinner skin) because of the increased risk of systemic side effects. Use in children can rapidly cause adrenal cortex suppression and also growth hormone suppression. The safety and efficacy of hydrocortisone in children aged < 1 month have not been established.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
ANTIFUNGALS FOR TOPICAL USE
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Antibiotics | ||
|---|---|---|
| D01AA01 | ||
| Imidazole and triazole derivatives | ||
|---|---|---|
| D01AC01 | ||
| D01AC08 | ||
| D01AC02 | ||
| D01AC09 | ||
| Other antifungals for topical use | ||
|---|---|---|
| D01AE14 | ||
| D01AE13 | ||
| D01AE15 | ||
| IMIDAZOLE AND TRIAZOLE DERIVATIVES | ||
|---|---|---|
| D01AC01 | ||
| D01AC08 | ||
| D01AC02 | ||
| D01AC09 | ||
| OTHER ANTIFUNGALS FOR TOPICAL USE | ||
|---|---|---|
| D01AE14 | ||
| D01AE13 | ||
| D01AE15 | ||
Reference
- Janssen-Cilag BV, SmPC Daktacort (RVG 07342) 14-09-2018, www.geneesmiddeleninformatiebank.nl
Changes
Therapeutic Drug Monitoring
Overdose
